Qube Research & Technologies (QRT)
APGE

Qube Research & Technologies (QRT)’s Apogee Therapeutics APGE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.6M Buy
+659,678
New +$59.4M 0.08% 329
2026
Q1 		– Sell
-14,283
Closed -$1.08M – 3518
2025
Q4 		$1.08M Buy
+14,283
New +$900K ﹤0.01% 2528
2024
Q2 		– Sell
-2,264
Closed -$150K – 3775
2024
Q1 		$150K Buy
+2,264
New +$98.8K ﹤0.01% 3150

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Qube Research & Technologies (QRT)'s APGE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 659,678 shares worth $87.6M. The stake represents 0.08% of the portfolio and ranks #329 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in APGE as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in APGE in Q1 2024 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 659,678 shares of Apogee Therapeutics worth $87.6M as of Q2 2026.
  • Apogee Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Apogee Therapeutics made up 0.08% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #329 holding.
  • Qube Research & Technologies (QRT) first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.